The surgical medical specialty has matured to deliver in-depth and precise clinical outcomes for both doctors and patients, as well as to enhance surgical workflow patterns in healthcare systems. In comparison to prior eras, the healthcare sector is now integrating more advanced technology that is more informed and connected. The use of robotic-assisted imaging technologies makes diagnosis and surgery safer for patients by making it more precise and minimally invasive.
The global robotic-assisted imaging technologies market products include X-ray, CT, ultrasound, MRI, and others under the imaging modalities segment. It can be further segmented based on mobility and application. It is categorized as stationary and portable segments based on mobility, whereas under the application segment, it is categorized as diagnosis and imaging and treatment.
The global robotic-assisted imaging technologies market was valued at $617.7 million in 2020 and is projected to reach $2,207.8 million by the end of 2030, growing at a CAGR of 13.74% during the forecast period 2021-2030.
Market Drivers
Presently, the factors driving the growth of the market include rise in minimally invasive surgical procedures across the globe, evolution in image modalities and features, and rise in applications of robotics in the medical field.
Market Challenges
The challenges that are restricting the growth of the market include robotic failures leading to a low rate of adoption, lack of acceptance of robotic procedures, and safety and privacy concerns related to patient data.
Market Opportunities
Potential opportunities that are likely to boost the growth of the market include increased prevalence for misdiagnosis makes way for robotics in diagnostics and surgery domains high growth opportunities in emerging economies.
Impact of COVID-19
The COVID-19 pandemic had an ambiguous impact on the robotic-assisted imaging technologies market. Few of the imaging modalities, such as X-ray and CT, were used for screening during the COVID-19 pandemic, whereas the majority of the imaging modalities were not used due to postponement of elective surgeries and procedures during the pandemic. In the first half of 2020, the COVID-19 pandemic had a significant influence on elective surgical procedures. On a global scale, the COVID-19 pandemic also significantly impacted regular hospital routine services. During the early stages of the pandemic, hospitals drastically restricted or stopped performing elective surgical procedures to ensure patient safety and to focus on COVID-19 patients.
Key Market Players and Competition Synopsis
Some key players operating in the market include Brainlab AG, Digisens SAS, Epica International, Inc. (Epica Human Health), General Electric Company, Globus Medical, Inc., Medirob AB, Medtronic plc, Neocis, Inc., Novasignal Corporation, Perfint Healthcare, Renishaw plc, Siemens Healthineers AG, Stereotaxis, Inc., and Trivitron Healthcare
The robotic-assisted imaging technologies market has witnessed several strategic and technological developments from January 2017- November 2021, undertaken by different market players to attain their respective market shares in this emerging domain. Some strategies covered in this segment are product development and upgradation, partnerships, collaborations, business expansion, funding activities, regulatory approvals, mergers, and acquisitions. The preferred strategy for companies has been regulatory activities.
Key questions answered in the report
• What are the key trends that have a strong influence on the global robotic-assisted imaging technologies market? How did the COVID-19 pandemic impact the growth of the robotic-assisted imaging technologies market?
• What are the key development strategies which are implemented by the key players to maintain and capture market share?
• How does the patent landscape of robotic-assisted imaging technologies look like?
• What are the major market drivers, challenges, and opportunities in the global robotic-assisted imaging technologies market?
• Which leading companies are dominating the global robotic-assisted imaging technologies market?
• What are the regulations about the global robotic-assisted imaging technologies market?
• What was the market value of the leading segments and sub-segments of the global robotic-assisted imaging technologies market?
• How is each segment of the global robotic-assisted imaging technologies market expected to grow during the forecast period, and what is the expected revenue to be generated by each of the segments by the end of 2030?
• Which region carries the potential for the significant expansion of key companies within the robotic-assisted imaging technologies market?
Request a sample - https://bisresearch.com/requestsample?id=1234type=download
BIS Research Related Market Studies:
The Global Breast Imaging Technologies Market size valued to USD 3.54 billion in 2019, is predicted an elevation up-to USD 7.43 billion by 2030, with a growing CAGR of 6.90% from 2020-2030.The breast imaging technology is a branch of diagnostic radiology that deals with the imaging of breasts for screening and diagnosis purpose.
It provides high-resolution images of breast tissues using x-rays, MRI, sonography, and other breast imaging modalities.
The ionizing and non-ionizing imaging modalities, assist in the early detection and examination of breast diseases, especially breast cancer in women.Access Full Description of this report at:- https://www.nextmsc.com/report/breast-imaging-technologies-marketTop Companies: GE Healthcare, Hologic, Inc., Fujifilms Holdings Corp., SonoCine, Inc., Philips Healthcare, Gamma Medica, Inc., Siemens Healthcare, Toshiba Corporation, Dilon Technologies, Inc., Aurora Imaging Technology, Inc. and others.The breast imaging technologies market share analysis is based on technology and geography.
The ionizing segment is further divided into full-field digital mammography, cone-beam computed tomography, analog mammography, positron emission tomography & computed tomography, positron emission mammography, electric impedance tomography, 3D breast tomosynthesis, and MBI/BSGI.
Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.Request sample copy of this report at:- https://www.nextmsc.com/Breast-Imaging-Technologies-Market/request-sampleNorth America is expected to dominate the global breast imaging market, accounting for the highest market shares.
This is attributed to factors such as well-established healthcare infrastructures, better reimbursement facility, higher adoption of advanced medical technologies, higher investments in R activities, presence of key players and cutting-edge product launches.
